Company Filing History:
Years Active: 2022-2025
Title: The Innovations of Daniel W. Sherbenou
Introduction
Daniel W. Sherbenou is a notable inventor based in Denver, Colorado. He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Sherbenou's work focuses on the development of anti-CD46 antibodies.
Latest Patents
Sherbenou's latest patents include groundbreaking methods for treating cancers characterized by modifications at biomarker 1q21. These patents disclose methods that involve administering a therapeutically effective amount of an anti-CD46 antibody to subjects suffering from such cancers. This innovative approach aims to improve treatment outcomes for patients.
Career Highlights
Daniel W. Sherbenou is affiliated with the University of California, where he continues to advance his research in the field of oncology. His work has garnered attention for its potential to change the landscape of cancer treatment.
Collaborations
Some of his notable coworkers include Blake T. Aftab and Yang Su, who contribute to the collaborative efforts in research and development within their field.
Conclusion
Daniel W. Sherbenou's contributions to cancer treatment through his patented innovations highlight the importance of research in developing effective therapies. His work exemplifies the impact that dedicated inventors can have on healthcare and patient outcomes.